Literature DB >> 12135360

Structural origins of the functional divergence of human insulin-like growth factor-I and insulin.

Andrzej M Brzozowski1, Eleanor J Dodson, Guy G Dodson, Garib N Murshudov, Chandra Verma, Johan P Turkenburg, Frederik M de Bree, Zbigniew Dauter.   

Abstract

Human insulin-like growth factors I and II (hIGF-I, hIGF-II) are potent stimulators of cell and growth processes. They display high sequence similarity to both the A and B chains of insulin but contain an additional connecting C-domain, which reflects their secretion without specific packaging or precursor conversion. IGFs also have an extension at the C-terminus known as the D-domain. This paper describes four homologous hIGF-1 structures, obtained from crystals grown in the presence of the detergent SB12, which reveal additional detail in the C- and D-domains. Two different detergent binding modes observed in the crystals may reflect different hIGF-I biological properties such as the interaction with IGF binding proteins and self-aggregation. While the helical core of hIGF-I is very similar to that in insulin, there are distinct differences in the region of hIGF-I corresponding to the insulin B chain C-terminus, residues B25-B30. In hIGF-I, these residues (24-29) and the following C-domain form an extensive loop protruding 20 A from the core, which results in a substantially different conformation for the receptor binding epitope in hIGF-I compared to insulin. One notable feature of the structures presented here is demonstration of peptide-bond cleavage between Ser35 and Arg36 resulting in an apparent gap between residues 35 and 39. The equivalent region of proinsulin is involved in hormone processing demanding a reassessment of the structural integrity of hIGF-I in relation to its biological function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12135360     DOI: 10.1021/bi020084j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  34 in total

1.  Contact-based sequence alignment.

Authors:  Jens Kleinjung; John Romein; Kuang Lin; Jaap Heringa
Journal:  Nucleic Acids Res       Date:  2004-04-30       Impact factor: 16.971

2.  Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia.

Authors:  Hiroyuki Yamada; Kazutoshi Iijima; Osamu Tomita; Tomoko Taguchi; Masashi Miharu; Kenichiro Kobayashi; Hajime Okita; Masahiro Saito; Toshiaki Shimizu; Nobutaka Kiyokawa
Journal:  Int J Hematol       Date:  2012-12-19       Impact factor: 2.490

3.  Ensemble MD simulations restrained via crystallographic data: accurate structure leads to accurate dynamics.

Authors:  Yi Xue; Nikolai R Skrynnikov
Journal:  Protein Sci       Date:  2014-04       Impact factor: 6.725

Review 4.  Obesity, diabetes and cancer: insight into the relationship from a cohort with growth hormone receptor deficiency.

Authors:  Jaime Guevara-Aguirre; Arlan L Rosenbloom
Journal:  Diabetologia       Date:  2014-10-15       Impact factor: 10.122

5.  An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein.

Authors:  Michael D Glidden; Khadijah Aldabbagh; Nelson B Phillips; Kelley Carr; Yen-Shan Chen; Jonathan Whittaker; Manijeh Phillips; Nalinda P Wickramasinghe; Nischay Rege; Mamuni Swain; Yi Peng; Yanwu Yang; Michael C Lawrence; Vivien C Yee; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2017-11-07       Impact factor: 5.157

6.  Protective hinge in insulin opens to enable its receptor engagement.

Authors:  John G Menting; Yanwu Yang; Shu Jin Chan; Nelson B Phillips; Brian J Smith; Jonathan Whittaker; Nalinda P Wickramasinghe; Linda J Whittaker; Vijay Pandyarajan; Zhu-li Wan; Satya P Yadav; Julie M Carroll; Natalie Strokes; Charles T Roberts; Faramarz Ismail-Beigi; Wieslawa Milewski; Donald F Steiner; Virander S Chauhan; Colin W Ward; Michael A Weiss; Michael C Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

7.  IPF pathogenesis is dependent upon TGFβ induction of IGF-1.

Authors:  Danielle M Hernandez; Jeong-Han Kang; Malay Choudhury; Mahefatiana Andrianifahanana; Xueqian Yin; Andrew H Limper; Edward B Leof
Journal:  FASEB J       Date:  2020-02-17       Impact factor: 5.191

8.  Design of an insulin analog with enhanced receptor binding selectivity: rationale, structure, and therapeutic implications.

Authors:  Ming Zhao; Zhu-li Wan; Linda Whittaker; Bin Xu; Nelson B Phillips; Panayotis G Katsoyannis; Faramarz Ismail-Beigi; Jonathan Whittaker; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-09-22       Impact factor: 5.157

9.  Contribution of residue B5 to the folding and function of insulin and IGF-I: constraints and fine-tuning in the evolution of a protein family.

Authors:  Youhei Sohma; Qing-xin Hua; Ming Liu; Nelson B Phillips; Shi-Quan Hu; Jonathan Whittaker; Linda J Whittaker; Aubree Ng; Charles T Roberts; Peter Arvan; Stephen B H Kent; Michael A Weiss
Journal:  J Biol Chem       Date:  2009-12-03       Impact factor: 5.157

10.  Harmonic oscillator model of the insulin and IGF1 receptors' allosteric binding and activation.

Authors:  Vladislav V Kiselyov; Soetkin Versteyhe; Lisbeth Gauguin; Pierre De Meyts
Journal:  Mol Syst Biol       Date:  2009-02-17       Impact factor: 11.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.